Fig. 2From: Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a reviewSchematic representation of various action of NSAIDs through different targets and its consequences in various conditions and cancer types. NSAIDS have been known to inhibit NF-KB, COX-1, COX-2, 5 LOX, PAF, and PP2A respectively, and supress EGFR in different cancer typesBack to article page